Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Don’t Pen Value Investing’s Obit Just Yet

BY | ETF Database
12:42 pm ET 08/07/26 | 3 VIEWS
  • Related Symbols
  • RPV
The purported death of value investing is widely lamented, but the reality is something different. Value investing is alive, but value stocks have long lagged growth counterparts. Still, there’s a compelling case for buying discounted equities, particularly when the right strategy is deployed.The Invesco S&P 500 Pure Value ETF (RPV B+) accomplishes that objective. RPV tracks the S&P 500® Pure Value Index. That factoid carries weight, because that gauge differs from the traditional S&P 500 Value Index. Confirming that, over the three years ending August 5, RPV beat one of the largest ETFs tracking the S&P 500 Value Index by 1,140 basis points. So, while RPV is unlikely to deliver growth ETF-like performances, it may be ideal for investors looking for more potential upside than that found by standard value ETFs. The $1.71 billion RPV, which holds 121 stocks, turned 20 years old in March. It’s seen its share of market cycles, including those in which growth equities dominated.RPV Enhances Value InvestingMany investors assume that value investing is simply about buying strong companies at favorable prices and to an extent, that’s accurate. “Value investing is built around a basic idea: Investors should buy stocks at a price below the value of their underlying businesses,” said Morningstar’s Daniel Sotiroff. “The gap between a stock’s price and the business’s true value is the edge. In theory, the market should eventually recognize the discount and increase the stock’s price to the investor’s advantage. Effectively, value investors are hunting for mispriced stocks that are trading at bargain prices.” RPV builds on the value proposition by focusing on value traits such as book-value-to-price ratio, earnings-to-price ratio, and sales-to-price ratio. Meanwhile, it layers in growth elements. Those include three-year sales per share growth, the three-year ratio of earnings per share change to price per share, and momentum, according to Invesco. For value investors, the RPV methodology could prove compelling because value investing is often a combination of art and science. That point’s not reflected by all of the ETFs in this category. “Assessing a business’s value is not a precise exercise. There is a degree of judgment involved, and some value investors likely consider a range of possible outcomes,” added Sotiroff. “But any investor engaged in this type of work has to be reasonably accurate often enough to make the effort worthwhile, and there’s a lot that can go wrong.” None of RPV’s holdings exceed a weight of 2.58%. Financial services, healthcare and consumer staples names combine for more than half of the fund’s roster. For more news, information, and analysis, visit the Innovative ETFs Content Hub. Invesco Distributors, Inc. is an independent company unaffiliated with VettaFi LLC (“VettaFi”). These articles do not form any kind of legal partnership, agency affiliation, or similar relationship between VettaFi and Invesco Distributors, Inc., nor is such a relationship created or implied by the articles herein. VettaFi LLC is the author and owner of these articles.

More Commentary

How the ETF Wrapper Unlocks Energy Stocks in FENY
BY | ETF Database
7:47 am ET 08/07/26 | 27 VIEWS
Midstream Companies Expand Natural Gas Pipelines as LNG & AI Demand Grows
BY | ETF Database
9:49 am ET 08/07/26 | 13 VIEWS
If ASML Is Awesome Again, This ETF Could Surge
BY | ETF Database
6:54 am ET 08/07/26 | 38 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.